Spruce Biosciences, Inc. (SPRB)
39.65
-1.82
(-4.39%)
USD |
NASDAQ |
Oct 16, 16:00
40.00
+0.35
(+0.88%)
After-Hours: 20:00
Spruce Biosciences Price to Book Value : 1.304 for Oct. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.304 |
| October 15, 2026 | 1.363 |
| October 14, 2026 | 1.282 |
| October 13, 2026 | 1.327 |
| October 12, 2026 | 1.409 |
| October 09, 2026 | 1.448 |
| October 08, 2026 | 1.497 |
| October 07, 2026 | 1.460 |
| October 06, 2026 | 1.407 |
| October 05, 2026 | 1.493 |
| October 02, 2026 | 1.503 |
| October 01, 2026 | 1.472 |
| September 30, 2026 | 1.597 |
| September 29, 2026 | 1.554 |
| September 28, 2026 | 1.562 |
| September 25, 2026 | 1.602 |
| September 24, 2026 | 1.612 |
| September 23, 2026 | 1.625 |
| September 22, 2026 | 1.644 |
| September 21, 2026 | 1.766 |
| September 18, 2026 | 1.744 |
| September 17, 2026 | 1.771 |
| September 16, 2026 | 1.781 |
| September 15, 2026 | 1.814 |
| September 14, 2026 | 1.869 |
| Date | Value |
|---|---|
| September 11, 2026 | 1.766 |
| September 10, 2026 | 1.787 |
| September 09, 2026 | 1.833 |
| September 08, 2026 | 1.943 |
| September 04, 2026 | 1.905 |
| September 03, 2026 | 1.897 |
| September 02, 2026 | 1.962 |
| September 01, 2026 | 1.828 |
| August 31, 2026 | 1.939 |
| August 28, 2026 | 1.998 |
| August 27, 2026 | 2.081 |
| August 26, 2026 | 2.021 |
| August 25, 2026 | 2.084 |
| August 24, 2026 | 1.928 |
| August 21, 2026 | 1.696 |
| August 20, 2026 | 1.709 |
| August 19, 2026 | 1.741 |
| August 18, 2026 | 1.737 |
| August 17, 2026 | 1.740 |
| August 14, 2026 | 1.731 |
| August 13, 2026 | 1.636 |
| August 12, 2026 | 1.548 |
| August 11, 2026 | 1.526 |
| August 10, 2026 | 1.519 |
| August 07, 2026 | 1.541 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.519 |
| Alnylam Pharmaceuticals, Inc. | 22.90 |
| Anika Therapeutics, Inc. | 1.948 |
| Savara, Inc. | 6.362 |
| Vericel Corp. | 5.549 |
Price to Book Value Related Metrics
| Price | 39.65 |
| Earnings Yield | -103.1% |
| Market Cap | 109.15M |